Newmark J, Brady R O, Grimley P M, Gal A E, Waller S G, Thistlethwaite J R
Proc Natl Acad Sci U S A. 1981 Oct;78(10):6513-6. doi: 10.1073/pnas.78.10.6513.
Amygdalin, the gentiobioside derivative of mandelonitrile commonly referred to as Laetrile, is presently under intensive investigation as a potential cancer chemotherapeutic agent. Because of this interest, we investigated the activity of beta-glucosidases that cleave glucose from amygdalin and from prunasin (mandelonitrile monoglucoside) in tissues from germ-free rats and in normal and neoplastic human tissues. Rat and human small intestinal mucosa contain high levels of activity of glucosidases that act on both of these cyanogenic glucosides. Release of glucose from these compounds was not detected in any of the human neoplastic tissues examined in the present study. These observations are consistent with reports of cyanide toxicity through the oral use of amygdalin or prunasin and pose serious questions concerning the alleged tumoricidal effect of amygdalin.
苦杏仁苷,通常被称为称为称为为扁桃腈的龙胆二糖苷衍生物,即所谓的维生素B17,目前正作为一种潜在的癌症化疗药物进行深入研究。出于这一兴趣,我们研究了在无菌大鼠组织以及正常和肿瘤性人类组织中,能从苦杏仁苷和樱草糖苷(扁桃腈单葡萄糖苷)上裂解葡萄糖的β-葡萄糖苷酶的活性。大鼠和人类小肠黏膜含有对这两种含氰葡萄糖苷均有作用的高水平葡萄糖苷酶活性。在本研究中检测的任何人类肿瘤组织中均未检测到这些化合物释放葡萄糖。这些观察结果与通过口服苦杏仁苷或樱草糖苷导致氰化物中毒的报道一致,并对苦杏仁苷所谓的杀肿瘤作用提出了严重质疑。